Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. decreased its position in Doximity, Inc. (NASDAQ:DOCS) by 48.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,599 shares of the company’s stock after selling 10,731 shares during the quarter. Lecap Asset Management Ltd.’s holdings in Doximity were worth $505,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its position in Doximity by 4.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 21,754 shares of the company’s stock valued at $948,000 after acquiring an additional 934 shares in the last quarter. Friedenthal Financial acquired a new stake in shares of Doximity during the third quarter worth approximately $799,000. Blue Trust Inc. grew its position in shares of Doximity by 107.2% during the third quarter. Blue Trust Inc. now owns 2,870 shares of the company’s stock worth $125,000 after buying an additional 1,485 shares in the last quarter. Trust Point Inc. grew its position in shares of Doximity by 16.9% during the third quarter. Trust Point Inc. now owns 28,809 shares of the company’s stock worth $1,255,000 after buying an additional 4,163 shares in the last quarter. Finally, Bleakley Financial Group LLC acquired a new stake in shares of Doximity during the third quarter worth approximately $213,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Buying and Selling at Doximity

In other Doximity news, CFO Anna Bryson sold 30,000 shares of the firm’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares in the company, valued at approximately $10,836,945. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of Doximity stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $25.54, for a total transaction of $25,820.94. Following the sale, the director now directly owns 11,258 shares in the company, valued at $287,529.32. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the sale, the chief financial officer now owns 309,627 shares in the company, valued at approximately $10,836,945. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 35,451 shares of company stock worth $1,201,018. 39.40% of the stock is owned by insiders.

Doximity Stock Performance

DOCS stock opened at $41.47 on Friday. The stock has a market capitalization of $7.69 billion, a price-to-earnings ratio of 57.60, a PEG ratio of 5.29 and a beta of 1.29. Doximity, Inc. has a 1 year low of $19.89 and a 1 year high of $44.88. The stock’s fifty day moving average is $39.86 and its two-hundred day moving average is $31.60.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.06. The company had revenue of $126.68 million for the quarter, compared to analysts’ expectations of $119.88 million. Doximity had a return on equity of 19.26% and a net margin of 32.53%. As a group, analysts predict that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on DOCS. Bank of America raised their price target on shares of Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a research report on Monday, October 7th. Canaccord Genuity Group raised their price target on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a research report on Friday, August 9th. Evercore ISI raised their price target on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Wells Fargo & Company cut Doximity from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $27.00 to $19.00 in a research note on Thursday, July 18th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Doximity currently has an average rating of “Hold” and a consensus price target of $35.83.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.